Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the patented CN101270038B method for synthesizing high-purity 4,4'-dihydroxybenzophenone using recycled carbon tetrachloride and solid superacid catalysts for cost-effective manufacturing.
Patent CN103492351B details efficient dehydrogenation oxidation for carbonyl compounds. Enables cost reduction in fine chemical manufacturing and reliable supply chain.
Patent CN116855467A reveals high-yield ergothioneine synthesis. Offers cost reduction and scalable supply chain solutions for nutritional ingredient manufacturing.
Novel IBX oxidation method for beta-carotene production. Achieves higher yields and purity with milder conditions. Ideal for food and feed additive manufacturing.
Patent CN113045446A details a safe, acidic synthesis for Glupa-C, eliminating explosion risks and toxic amines for reliable diagnostic reagent supply chains.
Novel patent CN119735538B details high-purity Brivaracetam production. This route offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturers.
Novel patent CN101270038B details a green synthesis of 4,4'-dihydroxybenzophenone using carbon tetrachloride and solid superacids, offering cost reduction and environmental compliance for pharmaceutical intermediates.
Novel chemo-enzymatic route for pseudouridine offers high purity and scalable production for mRNA vaccine manufacturers seeking reliable supply.
Novel zinc-mediated reduction route for Roxadustat intermediates. High purity, scalable, and cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN104193645A reveals efficient asymmetric synthesis. Delivers >99.5% ee. Ideal for Cilastatin production. Cost-effective supply chain solution for global buyers.
Patent CN115109759A reveals engineered carbonyl reductases achieving 600g/g S/C ratio. Discover cost-effective biocatalytic routes for chiral alcohol production.
Patent CN113234696B details a novel in vitro enzymatic route for crocetin from zeaxanthin, offering superior purity and scalable production for fine chemical manufacturing.
Patent CN108997355A reveals advanced recrystallization for Tofacitinib Citrate ensuring superior purity and yield for reliable pharmaceutical intermediates supplier partnerships.
Patent CN103159641A reveals low-cost lithiation route for tolvaptan intermediate ensuring high purity and supply chain stability for global pharmaceutical manufacturing.
Patent CN114196715A details a novel chemo-enzymatic method for pseudouridine using engineered glycosidase mutants, offering high conversion and simplified purification for mRNA vaccine supply chains.
Patent CN118374468B reveals mutant transaminase for high yield chiral amine intermediate production with improved stereoselectivity.
Patent CN105002234B reveals enzymatic cAMP synthesis. Offers high purity, cost reduction, and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN106191150A details a co-immobilized enzymatic method for D-alanine. Achieves >98% purity with continuous 55-day operation, offering significant supply chain stability and cost reduction.
Novel Ni-catalyzed photochemical synthesis offers cost reduction and high enantioselectivity for pharmaceutical intermediates manufacturing.
Novel ionic liquid method for cyclopentanone ensures high yield and purity. Ideal for pharma and agrochemical supply chains seeking cost reduction.